In a legal blow to German chemical giant Bayer’s Monsanto unit lost a final appeal in a marathon legal battle in France in which it has been held liable for the accidental inhalation of a weedkiller by a crop farmer. In… Read More ›
cancer
Bayer AG reaches $1.6 billion settlement agreement for U.S. lawsuits surrounding Essure birth control implantable device
German drugs and pesticides giant Bayer AG stated, it will pay around $1.6 billion to settle the majority of U.S. claims involving its Essure birth-control device. The agreement comes in the wake of a $10.9 billion settlement which it hammered… Read More ›
Roche’s research arm hires MIT’s prize-winning cancer researcher Aviv Regev
On Monday, Swiss pharmaceutical giant Roche stated, it has hired a professor from the Massachusetts Institute of Technology (MIT) as its new head of its U.S. research arm which was responsible for some of it’s best-selling medicines in the last… Read More ›
Bayer close to settling Roundup herbicide cases: mediator
In an interview to Bloomberg, Ken Feinberg, the mediator who is negotiating between cancer victims and Bayer stated, the the German pharmaceutical and life sciences company is close to settling more than 75,000 cancer claims related to its Roundup herbicide,… Read More ›
Drugmakers modestly hike U.S. drug prices
Drugmakers, including Gilead Sciences Inc, Bristol-Myers Squibb Co, and Biogen Inc have hiked their U.S. list prices on more than 50 drugs, according to data analyzed by 3 Axis Advisors, a healthcare research firm. On Tuesday, there were media reports… Read More ›
Bayer hires law firm Sidley Austin for investigating pan-Europe influence scheme by Monsanto
Bayer has its hands full due to U.S. class-action lawsuits revolving around Monsanto’s Roundup weed killer which has glyphosate which causes cancer. In a statement, Bayer AG said it has hired Sidley Austin, a law firm to investigate a Europe-wide… Read More ›
AstraZeneca Plc and Daiichi Sankyo Co Ltd sign lucrative cancer drug deal
The deal sees Britain’s AstraZeneca Plc led by Pascal Soriot sharing development and commercialization costs for the drug worldwide. For AstraZeneca the deal makes sense as it will replenish its pipeline as its cancer drug sales grow. In a significant… Read More ›
Legal costs will determine whether Bayer AG would settle glyphosate related cases
According to one of the attorneys for the plaintiff, Bayer’s claims on glyphosate were “hypocritical beyond belief” given its own efforts to control the message on glyphosate, the most recent of which is a full-page advertisement in the Washington Post…. Read More ›
French drugmaker Sanofi enters $100 billion cancer drug treatment market
Sanofi’s strength in molecular oncology is likely to provide it a competitive edge over its peers as to what drives the growth of cancer tissues, how these cells functions and proliferation in the body. In a strategic development, French drugmaker,… Read More ›
Roche Holding AG acquires Foundation Medicine for $2.4 billion
The strategic move will enable Roche Holding AG to add Foundation Medicine’s portfolio of drugs to its basket of cancer treatments. FMI’s molecular insights will also enable Roche to create and develop new cancer treatments. On Tuesday, Swiss drugmaker Roche… Read More ›
manageria.biz 